1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Kanamycin Sulfate Injection market is evolving rapidly in response to heightened antimicrobial resistance and shifting clinical workflows. Senior healthcare and procurement decision-makers face a landscape marked by ongoing formulation innovation, regulatory pressures, and cost variability, driving the need for clear, actionable intelligence.
Market Snapshot: Kanamycin Sulfate Injection
Kanamycin Sulfate Injection remains a cornerstone aminoglycoside antibiotic within global hospital and clinical settings, prized for its broad-spectrum efficacy against severe Gram-negative infections. Recently, demand has surged due to the spread of multidrug-resistant pathogens and changes in patient demographics, including an aging population. The market is adapting, as hospitals, clinics, and home healthcare providers increasingly require both lyophilized powders and ready-to-use formulations. Growing attention to antibiotic stewardship, combined with the adoption of digital health tools for infusion and administration, further shapes usage patterns and procurement standards.
Scope & Segmentation
This report analyzes Kanamycin Sulfate Injection by multiple factors, providing comprehensive insight into market structure and critical opportunities. Key segmentation includes:
- Application: Respiratory infections (community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia), septicemia, skin and soft tissue infections, urinary tract infections
- End User: Clinics (independent or hospital-affiliated), hospitals (public and private), and home healthcare providers
- Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies (chains and independents)
- Dosage Strength: 500 mg, 1 g, and 2 g vials
- Formulation: Lyophilized powder, ready-to-use solution
- Major Regions: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and more), Asia-Pacific (spanning China, India, Japan, Australia, South Korea, and many others)
- Key Companies: Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Lupin Limited, Cipla Limited, Pfizer Inc.
Key Takeaways for Senior Decision-Makers
- Kanamycin Sulfate Injection is still integral for treating severe, multidrug-resistant Gram-negative infections—especially when first-line agents are ineffective.
- Advanced ready-to-use and refined lyophilized formulations simplify workflows, supporting both hospital-based and outpatient care environments.
- Adoption of real-time infusion monitoring, electronic prescribing, and improved pathogen diagnostics is enhancing precision in clinical settings.
- Shifting regulatory and tariff frameworks require proactive sourcing and supply chain adaptation, with many organizations forming partnerships with domestic API producers.
- Regional differences in infrastructure, funding, and regulatory harmonization drive unique access challenges and opportunities, making flexible strategy essential.
Tariff Impact: United States 2025 Developments
The 2025 revisions of United States tariffs on imported active pharmaceutical ingredients directly affected supply chain economics for Kanamycin Sulfate Injection. Increased duties on raw materials resulted in higher production costs, prompting manufacturers to diversify sourcing from lower-tariff regions and secure stability with long-term supplier agreements. Domestic API manufacturing partnerships and optimized logistics, such as consolidated shipments and regional distribution hubs, have emerged as key strategies to counterbalance added cost pressures and to ensure compliance with evolving regulations.
Methodology & Data Sources
This analysis uses a hybrid approach, combining primary interviews with hospital pharmacists, procurement directors, formulation scientists, and regulatory experts, alongside secondary research across scientific journals, regulatory filings, public health reports, and patent databases. Data triangulation and rigorous segmentation help ensure reliability and meaningful insights for strategic planning.
Why This Report Matters
- Offers clarity on how clinical, regulatory, and economic forces are reshaping Kanamycin Sulfate Injection market dynamics for pharmaceutical executives and supply leaders.
- Supports more effective sourcing, procurement, and product planning in response to resistance trends and tariff-driven supply chain changes.
- Aligns go-to-market and investment strategies with evolving patient care models and regional priorities.
Conclusion
Kanamycin Sulfate Injection retains central importance in antibacterial therapy amidst new resistance and regulatory challenges. Strategic agility and data-driven planning will position stakeholders for continued operational success and improved patient outcomes.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing prevalence of multidrug-resistant tuberculosis driving demand for Kanamycin Sulfate Injection in high-burden markets
5.2. Intensified regulatory scrutiny of injectable aminoglycosides safety protocols influencing Kanamycin Sulfate Injection approval timelines
5.3. Expansion of low-cost generic Kanamycin Sulfate Injection manufacturers in Asia Pacific intensifying global price competition
5.4. Emergence of combination therapy regimens pairing Kanamycin Sulfate Injection with novel antimicrobials to reduce nephrotoxicity risks
5.5. Supply chain disruptions in fermentation-derived Kanamycin API causing periodic shortages and pricing volatility in regional markets
5.6. Adoption of digital cold chain monitoring solutions by distributors to optimize Kanamycin Sulfate Injection storage and minimize wastage
5.2. Intensified regulatory scrutiny of injectable aminoglycosides safety protocols influencing Kanamycin Sulfate Injection approval timelines
5.3. Expansion of low-cost generic Kanamycin Sulfate Injection manufacturers in Asia Pacific intensifying global price competition
5.4. Emergence of combination therapy regimens pairing Kanamycin Sulfate Injection with novel antimicrobials to reduce nephrotoxicity risks
5.5. Supply chain disruptions in fermentation-derived Kanamycin API causing periodic shortages and pricing volatility in regional markets
5.6. Adoption of digital cold chain monitoring solutions by distributors to optimize Kanamycin Sulfate Injection storage and minimize wastage
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Kanamycin Sulfate Injection Market, by Application
8.1. Introduction
8.2. Respiratory Infections
8.2.1. Community Acquired Pneumonia
8.2.2. Hospital Acquired Pneumonia
8.2.3. Ventilator Associated Pneumonia
8.3. Septicemia
8.4. Skin and Soft Tissue Infections
8.5. Urinary Tract Infections
8.2. Respiratory Infections
8.2.1. Community Acquired Pneumonia
8.2.2. Hospital Acquired Pneumonia
8.2.3. Ventilator Associated Pneumonia
8.3. Septicemia
8.4. Skin and Soft Tissue Infections
8.5. Urinary Tract Infections
9. Kanamycin Sulfate Injection Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Hospital Affiliated Clinics
9.2.2. Independent Clinics
9.3. Home Healthcare
9.4. Hospitals
9.4.1. Government Hospitals
9.4.2. Private Hospitals
9.2. Clinics
9.2.1. Hospital Affiliated Clinics
9.2.2. Independent Clinics
9.3. Home Healthcare
9.4. Hospitals
9.4.1. Government Hospitals
9.4.2. Private Hospitals
10. Kanamycin Sulfate Injection Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Kanamycin Sulfate Injection Market, by Dosage Strength
11.1. Introduction
11.2. 1 G Vial
11.3. 2 G Vial
11.4. 500 Mg Vial
11.2. 1 G Vial
11.3. 2 G Vial
11.4. 500 Mg Vial
12. Kanamycin Sulfate Injection Market, by Formulation
12.1. Introduction
12.2. Lyophilized Powder
12.3. Ready to Use Solution
12.2. Lyophilized Powder
12.3. Ready to Use Solution
13. Americas Kanamycin Sulfate Injection Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Kanamycin Sulfate Injection Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Kanamycin Sulfate Injection Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sandoz International GmbH
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Fresenius Kabi AG
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Dr. Reddy's Laboratories Ltd.
16.3.8. Lupin Limited
16.3.9. Cipla Limited
16.3.10. Pfizer Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sandoz International GmbH
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Fresenius Kabi AG
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Dr. Reddy's Laboratories Ltd.
16.3.8. Lupin Limited
16.3.9. Cipla Limited
16.3.10. Pfizer Inc.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. KANAMYCIN SULFATE INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. KANAMYCIN SULFATE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. KANAMYCIN SULFATE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHAI
FIGURE 26. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. KANAMYCIN SULFATE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. KANAMYCIN SULFATE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHAI
FIGURE 26. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. KANAMYCIN SULFATE INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. KANAMYCIN SULFATE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY VENTILATOR ASSOCIATED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY VENTILATOR ASSOCIATED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SEPTICEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SEPTICEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 1 G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 1 G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 2 G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 2 G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 500 MG VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 500 MG VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY READY TO USE SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY READY TO USE SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 118. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 119. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 130. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 131. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 282. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 283. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 292. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 293. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 306. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 307. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 310. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 311. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY VENTILATOR ASSOCIATED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY VENTILATOR ASSOCIATED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SEPTICEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SEPTICEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 1 G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 1 G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 2 G VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 2 G VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 500 MG VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY 500 MG VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY READY TO USE SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY READY TO USE SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES KANAMYCIN SULFATE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 118. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 119. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 130. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 131. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 282. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 283. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 292. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 293. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 294. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 295. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY KANAMYCIN SULFATE INJECTION MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 306. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 307. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 310. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 311. SPAIN KANAMYCIN SULFATE INJECTION MARKET SIZE, BY
Samples
LOADING...
Companies Mentioned
The companies profiled in this Kanamycin Sulfate Injection market report include:- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Fresenius Kabi AG
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Lupin Limited
- Cipla Limited
- Pfizer Inc.
